Elderly patients with stage II gastric cancer do not benefit from adjuvant chemotherapy

BACKGROUND: With the aging of the population, the burden of elderly gastric cancer (EGC) increases worldwide. However, there is no consensus on the definition of EGC and the efficacy of adjuvant chemotherapy in patients with stage II EGC. Here, we investigated the effectiveness of adjuvant chemother...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Jianping, Xiong, Zhizhong, Yin, Shi, Wen, Yue’e, Jin, Longyang, Wang, Caiqin, Chen, Huaxian, Luo, Dandong, Deng, Zijian, Huang, Dayin, Li, Xianzhe, Yi, Biying, Mao, Chaobin, Lian, Lei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10566074/
https://www.ncbi.nlm.nih.gov/pubmed/37821872
http://dx.doi.org/10.1186/s12957-023-03185-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10566074/
https://www.ncbi.nlm.nih.gov/pubmed/37821872
http://dx.doi.org/10.1186/s12957-023-03185-5

Ejemplares similares